Molli Neilson, PA-C

NPI: 1700305265
Total Payments
$7,045
2024 Payments
$5,272
Companies
21
Transactions
130
Medicare Patients
1,708
Medicare Billing
$124,220

Payment Breakdown by Category

Other$4,250 (60.3%)
Food & Beverage$2,653 (37.7%)
Travel$141.70 (2.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,250 6 60.3%
Food and Beverage $2,653 119 37.7%
Travel and Lodging $141.70 5 2.0%

Top Paying Companies

Company Total Records Latest Year
Optinose US, Inc. $5,312 65 $0 (2024)
Intersect ENT, Inc. $418.69 10 $0 (2022)
Stryker Corporation $324.59 7 $0 (2024)
GENZYME CORPORATION $321.83 15 $0 (2024)
Regeneron Healthcare Solutions, Inc. $286.69 11 $0 (2024)
Acclarent, Inc $47.25 2 $0 (2021)
AERIN MEDICAL INC. $44.42 3 $0 (2024)
Amgen Inc. $36.07 2 $0 (2024)
Kowa Pharmaceuticals America, Inc. $31.83 2 $0 (2023)
kaleo, Inc. $31.10 2 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,272 51 Optinose US, Inc. ($4,682)
2023 $679.90 27 Optinose US, Inc. ($355.59)
2022 $564.67 22 Stryker Corporation ($196.67)
2021 $528.51 30 Intersect ENT, Inc. ($302.37)

All Payment Transactions

130 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/20/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $17.00 General
Category: IMMUNOLOGY
12/19/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $15.92 General
Category: Immunology
12/19/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $6.42 General
Category: Otolaryngology (Ear, Nose, Throat)
12/05/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $18.97 General
Category: Otolaryngology (Ear, Nose, Throat)
12/05/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $1.84 General
Category: Otolaryngology (Ear, Nose, Throat)
12/04/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $18.65 General
Category: Immunology
11/20/2024 Phathom Pharmaceuticals, Inc. VOQUEZNA (Drug) Food and Beverage In-kind items and services $13.26 General
Category: GASTROENTEROLOGY
11/19/2024 Optinose US, Inc. Xhance (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $650.00 General
Category: Otolaryngology (Ear, Nose, Throat)
11/19/2024 Optinose US, Inc. Xhance (Drug) Travel and Lodging Cash or cash equivalent $38.15 General
Category: Otolaryngology (Ear, Nose, Throat)
11/19/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $21.06 General
Category: Otolaryngology (Ear, Nose, Throat)
11/15/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $21.30 General
Category: Immunology
11/12/2024 Optinose US, Inc. Xhance (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $650.00 General
Category: Otolaryngology (Ear, Nose, Throat)
11/12/2024 Optinose US, Inc. Xhance (Drug) Travel and Lodging Cash or cash equivalent $32.70 General
Category: Otolaryngology (Ear, Nose, Throat)
11/12/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $22.44 General
Category: Otolaryngology (Ear, Nose, Throat)
11/06/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $18.71 General
Category: Inflammation
11/01/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $16.72 General
Category: Otolaryngology (Ear, Nose, Throat)
11/01/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $2.19 General
Category: Otolaryngology (Ear, Nose, Throat)
10/18/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $23.07 General
Category: Immunology
10/17/2024 AERIN MEDICAL INC. VIVAER STYLUS (Device), RHINAER STYLUS Food and Beverage In-kind items and services $13.60 General
Category: EAR NOSE & THROAT
10/15/2024 Optinose US, Inc. Xhance (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $650.00 General
Category: Otolaryngology (Ear, Nose, Throat)
10/15/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $27.36 General
Category: Otolaryngology (Ear, Nose, Throat)
10/15/2024 Optinose US, Inc. Xhance (Drug) Travel and Lodging Cash or cash equivalent $5.45 General
Category: Otolaryngology (Ear, Nose, Throat)
10/10/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $36.61 General
Category: INFLAMMATION AND IMMUNOLOGY
10/03/2024 Optinose US, Inc. Xhance (Drug) Food and Beverage In-kind items and services $6.94 General
Category: Otolaryngology (Ear, Nose, Throat)
10/01/2024 Optinose US, Inc. Xhance (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $650.00 General
Category: Otolaryngology (Ear, Nose, Throat)

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 10 419 647 $89,971 $30,934
2022 11 488 754 $94,333 $34,138
2021 12 471 684 $89,904 $37,580
2020 9 330 425 $60,743 $21,568
Total Patients
1,708
Total Services
2,510
Medicare Billing
$124,220
Procedure Codes
42

All Medicare Procedures & Services

42 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 122 186 $24,738 $9,450 38.2%
31231 Diagnostic exam of nasal passages using an endoscope Office 2023 40 53 $19,398 $5,479 28.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 57 74 $13,468 $4,716 35.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 28 37 $9,435 $4,073 43.2%
69210 Removal of impacted ear wax Office 2023 72 116 $9,164 $3,065 33.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 28 28 $7,112 $2,396 33.7%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 20 20 $3,340 $1,297 38.8%
96372 Injection of drug or substance under skin or into muscle Office 2023 26 39 $1,443 $335.22 23.2%
36415 Insertion of needle into vein for collection of blood sample Office 2023 12 13 $91.00 $89.18 98.0%
J0696 Injection, ceftriaxone sodium, per 250 mg Office 2023 14 81 $1,782 $32.75 1.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 137 218 $27,878 $12,045 43.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 99 123 $21,603 $8,415 39.0%
31231 Diagnostic exam of nasal passages using an endoscope Office 2022 41 52 $19,032 $5,908 31.0%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 41 41 $6,756 $2,659 39.4%
69210 Removal of impacted ear wax Office 2022 61 93 $7,347 $2,566 34.9%
31575 Diagnostic exam of voice box using a flexible endoscope Office 2022 18 19 $4,275 $1,204 28.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 13 13 $3,245 $870.96 26.8%
96372 Injection of drug or substance under skin or into muscle Office 2022 27 40 $1,480 $332.87 22.5%
36415 Insertion of needle into vein for collection of blood sample Office 2022 22 27 $189.00 $74.75 39.6%
J0696 Injection, ceftriaxone sodium, per 250 mg Office 2022 14 92 $2,024 $33.24 1.6%
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg Office 2022 15 36 $504.00 $28.86 5.7%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 138 206 $21,012 $10,910 51.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 95 135 $20,655 $10,793 52.3%
31231 Diagnostic examination of nasal passages using an endoscope Office 2021 41 66 $24,156 $7,774 32.2%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 35 35 $5,390 $2,077 38.5%

About Molli Neilson, PA-C

Molli Neilson, PA-C is a Physician Assistant healthcare provider based in Ogden, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2017. The National Provider Identifier (NPI) number assigned to this provider is 1700305265.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Molli Neilson, PA-C has received a total of $7,045 in payments from pharmaceutical and medical device companies, with $5,272 received in 2024. These payments were reported across 130 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($4,250).

As a Medicare-enrolled provider, Neilson has provided services to 1,708 Medicare beneficiaries, totaling 2,510 services with total Medicare billing of $124,220. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Location Ogden, UT
  • Active Since 09/15/2017
  • Last Updated 09/15/2017
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • NPI Number 1700305265

Products in Payments

  • Xhance (Drug) $5,312
  • DUPIXENT (Biological) $608.52
  • SINUVA (Drug) $227.63
  • PROPEL (Device) $191.06
  • ESSX (Device) $127.92
  • MEDLINE INDUSTRIES, INC. (Device) $100.14
  • LATERA (Device) $48.72
  • Relieva Spinplus (Device) $47.25
  • VIVAER STYLUS (Device) $44.42
  • TAVNEOS (Drug) $36.07
  • SEGLENTIS (Drug) $31.83
  • SCOPIS ENT (Device) $31.32
  • AUVI-Q (Drug) $31.10
  • HYQVIA (Biological) $21.58
  • KEVEYIS (Drug) $21.46
  • BAFIERTAM (Drug) $18.89
  • VYEPTI (Biological) $18.84
  • TYSABRI (Biological) $18.20
  • INSPIRE (Device) $17.46
  • NUCALA (Biological) $17.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in Ogden